Immunotherapy Drugs Extend Survival for Patients With Advanced Melanomas
MONDAY, Sept 16, 2024 -- A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced melanomas.
In 2011, a diagnosis of advanced, metastatic melanoma typically meant death within 6.5...